Cellulase Variants
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of:
- a. constructing a multiple alignment of at least two amino acid sequences known to have three-dimensional structures similar to endoglucanase V (EGV) from Humicola insolens known from Protein Data Bank entry 4ENG;
- b. constructing a homology-built three-dimensional structure of the cellulolytic enzyme based on the structure of the EGV;
- c. identifying amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å;
- d. identifying surface-exposed amino acid residues of the enzyme;
- e. identifying all charged or potentially charged amino acid residue positions of the enzyme;
- f. choosing one or more positions wherein the amino acid residue is to be substituted, deleted or where an insertion is to be provided; and
- g. carrying out the substitution, deletion or insertion by using conventional protein engineering techniques. Also described are cellulase variants obtained by this method.
18 Citations
85 Claims
-
1-78. -78. (canceled)
-
79. A method of producing an enzyme variant, comprising introduction a mutation in the amino acid sequence of a parent endoglucanase at one or more positions selected from the group consisting of:
-
2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 21a, 22, 24, 25, 26, 28, 29, 32, 33, 34, 35, 37, 40, 42, 42a, 43, 44, 45, 47, 48, 49, 49a, 49b, 50, 53, 54, 55, 58, 59, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 79, 80, 82, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 95, 95d, 95h, 95j, 96, 97, 98, 99, 100, 101, 102, 103, 104, 106, 110, 111, 112, 113, 114, 115, 116, 117, 119, 121, 123, 127, 128, 129, 130, 131, 132, 132a, 133, 134, 136, 137, 138, 139, 140, 140a, 141, 143a, 145, 146, 147, 148, 149, 150b, 150e, 150j, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160c, 160e, 160k, 161, 162, 163, 164, 165, 166, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 183, 184, 185, 186, 188, 191, 192, 193, 195, 196, 197, 200, and 201, wherein each mutation is independently a substitution, insertion or deletion, the enzyme variant has endoglucanase activity and each position is numbered according to the amino acid sequence of the cellulase of SEQ ID NO;
1. - View Dependent Claims (80, 81, 82, 83, 84, 85)
-
Specification